Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models

• Yukihiko Hiroshima,

  Affiliations AntiCancer, Inc., San Diego, California, United States of America, Department of Surgery, University of California San Diego, San Diego, California, United States of America, Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan

  ⨯
• Yong Zhang,

  Affiliation AntiCancer, Inc., San Diego, California, United States of America

  ⨯
• Ming Zhao,

  Affiliation AntiCancer, Inc., San Diego, California, United States of America

  ⨯
• Nan Zhang,

  Affiliation AntiCancer, Inc., San Diego, California, United States of America

  ⨯
• Takashi Murakami,

  Affiliation Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan

  ⨯
• Ali Maawy,

  Affiliation Department of Surgery, University of California San Diego, San Diego, California, United States of America

  ⨯
• Sumiyuki Mii,

  Affiliations AntiCancer, Inc., San Diego, California, United States of America, Department of Surgery, University of California San Diego, San Diego, California, United States of America

  ⨯
• Fuminari Uehara,

  Affiliations AntiCancer, Inc., San Diego, California, United States of America, Department of Surgery, University of California San Diego, San Diego, California, United States of America

  ⨯
• Mako Yamamoto,

  Affiliations AntiCancer, Inc., San Diego, California, United States of America, Department of Surgery, University of California San Diego, San Diego, California, United States of America

  ⨯
• Shinji Miwa,

  Affiliations AntiCancer, Inc., San Diego, California, United States of America, Department of Surgery, University of California San Diego, San Diego, California, United States of America

  ⨯
• Shuya Yano,

  Affiliations AntiCancer, Inc., San Diego, California, United States of America, Department of Surgery, University of California San Diego, San Diego, California, United States of America

  ⨯
• Masashi Momiyama,

  Affiliation Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan

  ⨯
• Ryutaro Mori,

  Affiliation Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan

  ⨯
• Ryusei Matsuyama,

  Affiliation Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan

  ⨯
• Takashi Chishima,

  Affiliation Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan

  ⨯
• Kuniya Tanaka,

  Affiliation Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan

  ⨯
• Yasushi Ichikawa,

  Affiliation Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan

  ⨯
• Michael Bouvet,

  Affiliation Department of Surgery, University of California San Diego, San Diego, California, United States of America

  ⨯
• Itaru Endo,

  Affiliation Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan

  ⨯
•  [ ... ],
• Robert M. Hoffman

  * E-mail: all@anticancer.com

  Affiliations AntiCancer, Inc., San Diego, California, United States of America, Department of Surgery, University of California San Diego, San Diego, California, United States of America

  ⨯
• [ view all ]
• [ view less ]